Triple

T16185313
Position Surface form Disambiguated ID Type / Status
Subject Office of Pharmaceutical Quality E392785 entity
Predicate partOf P40 FINISHED
Object Center for Drug Evaluation and Research E85252 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Center for Drug Evaluation and Research | Statement: [Office of Pharmaceutical Quality, partOf, Center for Drug Evaluation and Research]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Center for Drug Evaluation and Research
Context triple: [Office of Pharmaceutical Quality, partOf, Center for Drug Evaluation and Research]
  • A. Center for Drug Evaluation and Research chosen
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • B. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • C. Office of Generic Drugs
    The Office of Generic Drugs is a division of the U.S. Food and Drug Administration responsible for reviewing and approving generic medications to ensure they are safe, effective, and therapeutically equivalent to brand-name drugs.
  • D. Food and Drug Administration
    The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
  • E. Center for Devices and Radiological Health
    The Center for Devices and Radiological Health is the U.S. FDA division responsible for regulating medical devices and radiation-emitting products to ensure their safety and effectiveness.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d87f1e49ac8190a311b54d32990576 completed April 10, 2026, 4:39 a.m.
NER Named-entity recognition batch_69e22060dcf88190b7c662946a5f0191 completed April 17, 2026, 11:58 a.m.
NED1 Entity disambiguation (via context triple) batch_6a000ecd897c81908cbea306c9f95da3 completed May 10, 2026, 4:51 a.m.
Created at: April 10, 2026, 5:02 a.m.